These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 10910177)

  • 41. Epidemiologic, clinical, and therapeutic aspects of reactive arthritis and ankylosing spondylitis.
    Toivanen A; Toivanen P
    Curr Opin Rheumatol; 1995 Jul; 7(4):279-83. PubMed ID: 7547104
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ankylosing spondylitis and inflammatory bowel disease. II. Prevalence of peripheral arthritis, sacroiliitis, and ankylosing spondylitis in patients suffering from inflammatory bowel disease.
    Dekker-Saeys BJ; Meuwissen SG; Van Den Berg-Loonen EM; De Haas WH; Agenant D; Tytgat GN
    Ann Rheum Dis; 1978 Feb; 37(1):33-5. PubMed ID: 629601
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Different course of reactive arthritis in two HLA-B27 positive brothers with fatal outcome in one.
    Yli-Kerttula T; Möttönen T; Toivanen A
    J Rheumatol; 1997 Oct; 24(10):2047-50. PubMed ID: 9330954
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Microbial antigens mediate HLA-B27 diseases via TLRs.
    Pöllänen R; Sillat T; Pajarinen J; Levón J; Kaivosoja E; Konttinen YT
    J Autoimmun; 2009; 32(3-4):172-7. PubMed ID: 19299108
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Some aspects of pathogenesis of ankylosing spondylitis].
    Erdes Sh
    Ter Arkh; 2011; 83(5):51-6. PubMed ID: 21780658
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of HLA B27 in ankylosing spondylitis with human alloreactive cytolytic T lymphocyte clones: failure to detect disease-related T cell epitopes.
    Czitrom AA; Pototschnik R; Edwards S; Gladman DD; Falk JA
    Exp Clin Immunogenet; 1986; 3(3):129-37. PubMed ID: 2484102
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Second International Simmons Center Conference on HLA-B27-Related Disorders.
    Lipsky PE; Taurog JD
    Arthritis Rheum; 1991 Nov; 34(11):1476-82. PubMed ID: 1953825
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of HLA-B27 and subtypes of HLA-B27 associated with ankylosing spondylitis in Galicia, Spain.
    Fernández-Sueiro JL; Alonso C; Blanco FJ; Rodríguez-Gómez M; Galdo F; González-Gay MA
    Clin Exp Rheumatol; 2004; 22(4):465-8. PubMed ID: 15301245
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HLA B27 subtype distribution among patients with ankylosing spondylitis in eastern Turkey.
    Diyarbakir E; Eyerci N; Melikoglu M; Topcu A; Pirim I
    Genet Test Mol Biomarkers; 2012 May; 16(5):456-8. PubMed ID: 22621386
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Distribution of HLA-B27 in Romanian spondyloarthritides patients.
    Popa OM; Bojinca M; Bojinca V; Ciofu C; Dutescu MI; Bardan A; Sfrent-Cornateanu R; Petrek M; Bara C; Popa L
    Int J Immunogenet; 2010 Dec; 37(6):513-6. PubMed ID: 20572892
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Ankylosing spondylarthritis, HLA B27 and the theory of crossed tolerance].
    Ebringer A
    Rev Rhum Mal Osteoartic; 1983 Nov; 50(11):763-9. PubMed ID: 6364315
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [HLA-B27 molecular subtypes and spondylarthropathies].
    Tieng V; Charron D; Toubert A
    Pathol Biol (Paris); 1998 Dec; 46(10):737-40. PubMed ID: 9922989
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathogenesis of human leukocyte antigen B27-positive arthritis. Information from clinical materials.
    Märker-Hermann E; Höhler T
    Rheum Dis Clin North Am; 1998 Nov; 24(4):865-81, xi. PubMed ID: 9891715
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Microbial factors in spondyloarthropathies: insights from population studies.
    Leirisalo-Repo M; Hannu T; Mattila L
    Curr Opin Rheumatol; 2003 Jul; 15(4):408-12. PubMed ID: 12819467
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical features and followup study of HLA-B27 positive patients presenting with peripheral arthritis.
    Sambrook P; McGuigan L; Champion D; Edmonds J; Fleming A; Portek I
    J Rheumatol; 1985 Jun; 12(3):526-8. PubMed ID: 3876436
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An overview of clinical spectrum and heterogeneity of spondyloarthropathies.
    Khan MA
    Rheum Dis Clin North Am; 1992 Feb; 18(1):1-10. PubMed ID: 1561395
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Guilt by association: HLA-B27 and ankylosing spondylitis.
    Benjamin R; Parham P
    Immunol Today; 1990 Apr; 11(4):137-42. PubMed ID: 2187471
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The pathogenetic role of HLA-B27.
    Feltkamp TE; Khan MA; Lopez de Castro JA
    Immunol Today; 1996 Jan; 17(1):5-7. PubMed ID: 8652056
    [No Abstract]   [Full Text] [Related]  

  • 59. Ankylosing spondylitis and uveitis: overview.
    Gouveia EB; Elmann D; Morales MS
    Rev Bras Reumatol; 2012 Oct; 52(5):742-56. PubMed ID: 23090374
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spondyloarthritis: update on pathogenesis and management.
    Reveille JD; Arnett FC
    Am J Med; 2005 Jun; 118(6):592-603. PubMed ID: 15922688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.